Imricor Medical Systems, Inc (IMR)
20mins delayed
Movement
1 Year Return
Imricor Medical Systems, Inc Chart
| Share price | |
| Last | |
| Change | |
| Volume | |
| Turnover | |
| Market Cap | $83.97 million |
| Today's Movement | |
| Prev. Close | |
| Open | |
| Day Range | - |
| VWAP | |
| Historical Stats | |
| 52w Range | - |
| 4w Avg Volume | |
| 4w Avg Turnover | |
| (delayed) | |
IMR Statistics
07 April
746 / 2,256
ASX Size Rank
1yr Return
vs Sector (1yr)
-74.82%
vs ASX 200 (1yr)
-20.98%
$83.97 million
Market Cap
Share Issue
91.27 million
All Ords (%)
N/A
Short Sold
0%
Current Fundamentals
07 April
N/A
PE Ratio
EPS ($)
-
Earnings Yield
-
NTA ($)
-
N/A
Dividend Yield
DPS ($)
-
Gross Div. Yield
-
Gross DPS ($)
-
Company Overview
Imricor Medical Systems Inc (IMR) is a US based medical device company that seeks to address the current issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. The Company's primary product offering, the Vision-MR Ablation Catheter is specifically designed to work under real-time MRI guidance, with the intent of enabling higher success rates along with a faster and safer treatment compared to conventional procedures using x-ray guided catheters.
Upcoming Calendar
Dividend History
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| No dividends paid in the last 5 years | ||||
See Upcoming Dividends for all ASX companies.
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
IMR is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.
Directors & Management
| Name | Title | Since | Bio |
|---|---|---|---|
| Mr Peter McGregor | Non-Executive Director | May 2019 |
|
| Ms Doris Engibous | Non-Executive Director | Apr 2019 |
|
| Mr Steve Wedan | Chief Executive Officer, President, Executive Chairman, Executive Director | May 2006 |
|
| Mr Mark Tibbles | Non-Executive Director | Sep 2014 |
|
Director Transactions
IMR directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
| Date | Director | Type | Amount | Price | Value | Notes |
|---|---|---|---|---|---|---|
| 31/12/19 | Steve Wedan | Issued | 501 | $1.194 | $598 | Conversion of convertible notes. |
| 31/12/19 | Steve Wedan | Transfer | 2,518,219 | $1.195 | $3,009,271 | Off-market transfer. |
| 31/12/19 | Mark Tibbles | Issued | 2,897 | $1.195 | $3,461 | Conversion of convertible notes. |
| 24/12/19 | Mark Tibbles | Exercise | 30,000 | $0.341 | $10,230 | Exercise of options. |
| 24/12/19 | Mark Tibbles | Buy | +30,000 | $0.341 | $10,230 | Exercise of options. |
Shareholder Distribution
Shareholder Distribution data is unavailable.
Top 20 Shareholders
No data available. Most companies release Top 20 Shareholders data in their Annual Report but it's not compulsory.
IMR Share Price History
| Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
IMR Historical Data
Download up to 20 years of share price history.
| Year | Closing Price (30 June) | Last Trade |
|---|
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: Development of MRI-compatible medical devices to carry out MRI-guided cardiac catheter ablation procedures.
Incorporated: --
400 Gateway Bvd
Burnsville Minnesot USA 55337
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.